PB 43 of 2014

 

National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 4)

National Health Act 1953

I, ADRIANA PLATONA,  Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated              15             May 2014

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

 

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

 

 

 

 

Part 1   Preliminary

1 Name of Determination

 (1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 4).

 (2) This Determination may also be cited as PB 43 of 2014.

2 Commencement

  This Determination commences on 1 June 2014.

3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

  Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1    Amendments

 

(Section 3)

 

 

[1] Schedule 1, after item dealing with Fenofibrate

 

Insert

 

Ferric carboxymaltose

 

[2] Schedule 1, after item dealing with Tafluprost

 

Insert

 

Tapentadol